November 30, 2018 / 6:03 AM / 14 days ago

BRIEF-Newron Pharmaceuticals: Zambon Announces Approval And ARTG Listing Of Safinamide In Australia

Nov 30 (Reuters) - Newron Pharmaceuticals SpA:

* ZAMBON ANNOUNCES APPROVAL AND ARTG LISTING OF SAFINAMIDE IN AUSTRALIA FOR TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below